Optomed Oyj (OPTOMED.HE)
EUR 3.95
(3.27%)
EUR 3.95
(3.27%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.85 Million EUR | -27.95% |
| 2022 | 6.74 Million EUR | -18.08% |
| 2021 | 8.23 Million EUR | 6.55% |
| 2020 | 7.72 Million EUR | -30.03% |
| 2019 | 11.04 Million EUR | -2.52% |
| 2018 | 11.32 Million EUR | 84.06% |
| 2017 | 6.15 Million EUR | 62.37% |
| 2016 | 3.79 Million EUR | 1.55% |
| 2015 | 3.73 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 4.49 Million EUR | -7.55% |
| 2024 Q2 | 4.12 Million EUR | -8.22% |
| 2023 Q3 | 5.77 Million EUR | -4.8% |
| 2023 Q4 | 4.85 Million EUR | -15.88% |
| 2023 Q1 | 6.42 Million EUR | -4.78% |
| 2023 Q2 | 6.06 Million EUR | -5.53% |
| 2023 FY | 4.85 Million EUR | -27.95% |
| 2022 Q4 | 6.74 Million EUR | 6.42% |
| 2022 Q2 | 7.29 Million EUR | -3.52% |
| 2022 FY | 6.74 Million EUR | -18.08% |
| 2022 Q3 | 6.33 Million EUR | -13.19% |
| 2022 Q1 | 7.56 Million EUR | -8.09% |
| 2021 Q4 | 8.23 Million EUR | 7.34% |
| 2021 FY | 8.23 Million EUR | 6.55% |
| 2021 Q3 | 7.66 Million EUR | 13.3% |
| 2021 Q1 | 7.43 Million EUR | -3.72% |
| 2021 Q2 | 6.76 Million EUR | -9.01% |
| 2020 FY | 7.72 Million EUR | -30.03% |
| 2020 Q2 | 7.49 Million EUR | -1.32% |
| 2020 Q3 | 7.33 Million EUR | -2.08% |
| 2020 Q4 | 7.72 Million EUR | 5.3% |
| 2020 Q1 | 7.59 Million EUR | -31.24% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 FY | 11.04 Million EUR | -2.52% |
| 2019 Q4 | 11.04 Million EUR | 1.22% |
| 2019 Q3 | 10.9 Million EUR | 0.0% |
| 2018 Q4 | 11.32 Million EUR | 0.0% |
| 2018 FY | 11.32 Million EUR | 84.06% |
| 2017 FY | 6.15 Million EUR | 62.37% |
| 2016 FY | 3.79 Million EUR | 1.55% |
| 2015 FY | 3.73 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|